Ertugliflozin

CAT#: H326661

CAS#: 1210344-57-2


Description: Ertugliflozin, also known as also known as PF-04971729, is a potent and selective inhibitor of the sodium-dependent glucose cotransporter 2 and clinical candidate for the treatment of type 2 diabetes mellitus. clinical study showed that Ertugliflozin (1-25 mg/day) improved glycaemic control, body weight and blood pressure in patients with T2DM suboptimally controlled on metformin, and was well tolerated.

img

Synthetic Routes

Ertugliflozin - Synthetic Route 1

Ertugliflozin route01

Synthetic reference

Ertugliflozin - Synthetic Route 2

Ertugliflozin route02

Synthetic reference

Ertugliflozin - Synthetic Route 3

Ertugliflozin route03

Synthetic reference

Ertugliflozin - Synthetic Route 4

Ertugliflozin route04

Synthetic reference

Ertugliflozin - Synthetic Route 5

Ertugliflozin route05

Synthetic reference

Ertugliflozin - Synthetic Route 6

Ertugliflozin route06

Synthetic reference

Ertugliflozin - Synthetic Route 7

Ertugliflozin route07

Synthetic reference

Ertugliflozin - Synthetic Route 8

Ertugliflozin route08

Synthetic reference

Ertugliflozin - Synthetic Route 9

Ertugliflozin route09

Synthetic reference

Ertugliflozin - Synthetic Route 10

Ertugliflozin route010

Synthetic reference

Ertugliflozin - Synthetic Route 11

Ertugliflozin route011

Synthetic reference

Virginia V.; Andreou, Thanos; Koftis, Theoharis V.; Gallos, John K. Synthesis of ertugliflozin from D-glucose. Tetrahedron Letters. 2019, 60(14): 994-996.

Ertugliflozin - Synthetic Route 12

Ertugliflozin route012

Synthetic reference

Mascitti V, Maurer TS, Robinson RP, Bian J, Boustany-Kari CM, Brandt T, Collman BM, Kalgutkar AS, Klenotic MK, Leininger MT, Lowe A, Maguire RJ, Masterson VM, Miao Z, Mukaiyama E, Patel JD, Pettersen JC, Préville C, Samas B, She L, Sobol Z, Steppan CM, Stevens BD, Thuma BA, Tugnait M, Zeng D, Zhu T. Discovery of a clinical candidate from the structurally unique dioxa-bicyclo[3.2.1]octane class of sodium-dependent glucose cotransporter 2 inhibitors. J Med Chem. 2011, 54(8):2952-60